🎉   Please check out our new website over at books-etc.com.

Seller
Your price
£29.23
RRP: £30.99
Save £1.76 (6%)
Printed on Demand
Dispatched within 7-9 working days.

Bioinformatics and Computational Biology in Drug Discovery and Development

Edited by William T. Loging
Format: Paperback / softback
Publisher: Cambridge University Press, Cambridge, United Kingdom
Published: 19th Jul 2018
Dimensions: w 170mm h 244mm d 14mm
Weight: 412g
ISBN-10: 1108461158
ISBN-13: 9781108461153
Barcode No: 9781108461153
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
Computational biology drives discovery through its use of high-throughput informatics approaches. This book provides a road map of the current drug development process and how computational biology approaches play a critical role across the entire drug discovery pipeline. Through the use of previously unpublished, real-life case studies the impact of a range of computational approaches are discussed at various phases of the pipeline. Additionally, a focus section provides innovative visualisation approaches, from both the drug discovery process as well as from other fields that utilise large datasets, recognising the increasing use of such technology. Serving the needs of early career and more experienced scientists, this up-to-date reference provides an essential introduction to the process and background of drug discovery, highlighting how computational researchers can contribute to that pipeline.

New & Used

Seller Information Condition Price
-New£29.23
+ FREE UK P & P

What Reviewers Are Saying

Submit your review
Newspapers & Magazines
'We live in transformative times and perhaps big data and analytics represent a most interesting and essential concept of today. From the telescope to the microscope, our ability to peer into complexities of life has transformed humanity. Big data is the next major step in major transition. Bioinformatics and Computational Biology in Drug Discovery and Development is a road map to an inevitable future - a future where data define disease, diagnosis and drugs. This book is an essential companion for anyone in drug development who has one foot in the present and one in the future.' John Nosta, President, NOSTALAB